RT Journal Article
SR Electronic
T1 Non-Invasive Scale Measurement of Cardiac Output Compared with the Gold-Standard Direct Fick Method: A Feasibility Study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.28.21254243
DO 10.1101/2021.03.28.21254243
A1 Yazdi, Daniel
A1 Patel, Sarin
A1 Sridaran, Suriya
A1 Wilson, Evan
A1 Smith, Sarah
A1 Centen, Corey
A1 Gillon, Leah
A1 Kapur, Sunil
A1 Tracy, Julie A.
A1 Lewine, Katherine
A1 Systrom, David M.
A1 MacRae, Calum A.
YR 2021
UL http://medrxiv.org/content/early/2021/03/31/2021.03.28.21254243.abstract
AB Background Objective markers of cardiac function are limited in the outpatient setting and may be beneficial for monitoring patients with chronic cardiac conditions.Objective We assess the accuracy of a scale, with the ability to capture ballistocardiography, electrocardiography, and impedance plethysmography signals from a patient’s feet while standing on the scale, in measuring stroke volume and cardiac output compared to the gold-standard direct Fick method.Methods Thirty-two patients with unexplained dyspnea undergoing level 3 invasive cardiopulmonary exercise test at a tertiary medical center were included in the final analysis. We obtained scale and direct Fick measurements of stroke volume and cardiac output before and immediately after invasive cardiopulmonary exercise test.Results Stroke volume and cardiac output from a cardiac scale and the direct Fick method correlated with r = 0.81 and r = 0.85, respectively (P < 0.001 each). The mean absolute error of the scale estimated stroke volume was -1.58 mL, with a 95% limits of agreement (LOA) of -21.97 mL to 18.81 mL. The mean error for the scale estimated cardiac output was -0.31 L/min, with a 95% LOA of -2.62 L/min to 2.00 L/min. The change in stroke volume and cardiac output before and after exercise were 78.9% and 96.7% concordant, respectively between the two measuring methods.Conclusions This novel scale with cardiac monitoring abilities may allow for non-invasive, longitudinal measures of cardiac function. Using the widely accepted form factor of a bathroom scale, this method of monitoring can be easily integrated into a patient’s lifestyle.Competing Interest StatementDaniel Yazdi and Sarin Patel are employees at Bodyport Inc. Sarah Smith and Corey Centen are founders of Bodyport Inc. Calum A. MacRae is an advisor for Bodyport Inc.Funding StatementNo external funding was received for this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Approved by Brigham and Women's Hospital IRB.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data sets generated during and/or analyzed during the current study are not publicly available due their proprietary nature but are available from the corresponding author on reasonable request.BCGballistocardiographyECGelectrocardiographyHFheart failureiCPETinvasive cardiopulmonary exercise testIPGimpedance plethysmographyLOAlimits of agreementPEpercentage errorTPOTTree-based Pipeline Optimization Tool